SCHEMBL5067948

SCHEMBL5067948

CCCCC(N)(N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10804336 0.74 FDPS (0.38)
SCHEMBL2138683 0.72 FDPS (0.36)
SCHEMBL502512 0.72 FDPS (0.36)
SCHEMBL380309 0.72
SCHEMBL379537 0.71
SCHEMBL28422929 0.70 FDPS (0.34)
SCHEMBL1410618 0.70
SCHEMBL11776963 0.70
SCHEMBL21218214 0.69 FDPS (0.42)
SCHEMBL5028617 0.68 FDPS (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791246-B2 Enzymatic substrates for multiple detection systems PERKINELMER HEALTH SCIENCES, INC. (US) 2014-07-29 US claimed
US-6884868-B1 Cyclic hexapeptides having antibiotic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-04-26 US claimed
EP-1173472-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-23 EP claimed
WO-2000064927-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 WO claimed
US-20080154022-A1 Transport of basic fibroblast growth factor across the blood brain barrier THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-06-26 US disclosed
US-20040102369-A1 Transport of basic fibroblast growth factor across the blood brain barrier THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-05-27 US disclosed